| IL-1 family nomenclature C Dinarello, W Arend, J Sims, D Smith, H Blumberg, L O'Neill, ... Nature immunology 11 (11), 973-973, 2010 | 417 | 2010 |
| IL‐33 attenuates EAE by suppressing IL‐17 and IFN‐γ production and inducing alternatively activated macrophages HR Jiang, M Milovanović, D Allan, W Niedbala, AG Besnard, SY Fukada, ... European journal of immunology 42 (7), 1804-1814, 2012 | 367 | 2012 |
| Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus V Volarevic, N Arsenijevic, ML Lukic, M Stojkovic Stem cells 29 (1), 5-10, 2011 | 352 | 2011 |
| Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells IP Jovanovic, NN Pejnovic, GD Radosavljevic, JM Pantic, MZ Milovanovic, ... International journal of cancer 134 (7), 1669-1682, 2014 | 346 | 2014 |
| IL-33/ST2 axis in inflammation and immunopathology M Milovanovic, V Volarevic, G Radosavljevic, I Jovanovic, N Pejnovic, ... Immunologic research 52, 89-99, 2012 | 334 | 2012 |
| Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates H Saadi, SG Carruthers, N Nagelkerke, F Al-Maskari, B Afandi, R Reed, ... Diabetes research and clinical practice 78 (3), 369-377, 2007 | 256 | 2007 |
| Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis V Volarevic, A Al-Qahtani, N Arsenijevic, S Pajovic, ML Lukic Autoimmunity 43 (4), 255-263, 2010 | 220 | 2010 |
| Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis HR Jiang, Z Al Rasebi, E Mensah-Brown, A Shahin, D Xu, CS Goodyear, ... The Journal of Immunology 182 (2), 1167-1173, 2009 | 219 | 2009 |
| Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents JM Conlon, M Mechkarska, ML Lukic, PR Flatt Peptides 57, 67-77, 2014 | 210 | 2014 |
| Effector mechanisms in low-dose streptozotocin-induced diabetes ML Lukic, S Stošic-Grujicic, A Shahin Journal of Immunology Research 6 (1-2), 119-128, 1998 | 200 | 1998 |
| Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice ML Lukic, S Stosic-Grujicic, N Ostojic, WL Chan, FY Liew Biochemical and biophysical research communications 178 (3), 913-920, 1991 | 191 | 1991 |
| Galectin-3 deficiency accelerates high-fat diet–induced obesity and amplifies inflammation in adipose tissue and pancreatic islets NN Pejnovic, JM Pantic, IP Jovanovic, GD Radosavljevic, MZ Milovanovic, ... Diabetes 62 (6), 1932-1944, 2013 | 190 | 2013 |
| Protective role of IL-33/ST2 axis in Con A-induced hepatitis V Volarevic, M Mitrovic, M Milovanovic, I Zelen, I Nikolic, S Mitrovic, ... Journal of hepatology 56 (1), 26-33, 2012 | 189 | 2012 |
| ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma I Jovanovic, G Radosavljevic, M Mitrovic, V Lisnic Juranic, ANJ McKenzie, ... European journal of immunology 41 (7), 1902-1912, 2011 | 177 | 2011 |
| The cutaneous basophil response to phytohemagglutinin in chickens MJ Stadecker, M Lukic, A Dvorak, S Leskowitz The Journal of Immunology 118 (5), 1564-1568, 1977 | 176 | 1977 |
| Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse M Borovcanin, I Jovanovic, G Radosavljevic, SD Dejanovic, D Bankovic, ... Journal of psychiatric research 46 (11), 1421-1426, 2012 | 174 | 2012 |
| The roles of Galectin-3 in autoimmunity and tumor progression G Radosavljevic, V Volarevic, I Jovanovic, M Milovanovic, N Pejnovic, ... Immunologic research 52, 100-110, 2012 | 164 | 2012 |
| Galectin‐3 deficiency prevents concanavalin A–induced hepatitis in mice V Volarevic, M Milovanovic, B Ljujic, N Pejnovic, N Arsenijevic, U Nilsson, ... Hepatology 55 (6), 1954-1964, 2012 | 140 | 2012 |
| Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice B Ljujic, M Milovanovic, V Volarevic, B Murray, D Bugarski, S Przyborski, ... Scientific reports 3 (1), 2298, 2013 | 120 | 2013 |
| Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice EPK Mensah-Brown, Z Al Rabesi, A Shahin, M Al Shamsi, N Arsenijevic, ... Clinical Immunology 130 (1), 83-88, 2009 | 120 | 2009 |
